
IBG-BIOBANK contributes to the generation of high-quality scientific outputs by ensuring the reliable provision of high-quality biological specimens and comprehensive associated data to researchers. Collaborative projects support a wide range of scientific objectives, including the elucidation of disease mechanisms, the development of novel therapeutic approaches, and the advancement of innovative solutions in the field of personalized medicine.
ABF Pharmaceutical Services GmbH (2021–2028)
Biobank-based publications aim to disseminate scientific findings obtained from the processes of collecting, storing, and analyzing biological specimens. These publications present results related to innovative technologies used in biobanking, quality control methods for biological samples, optimization of long-term storage conditions, and data management practices. Accordingly, these publications contribute to advancing knowledge in essential areas such as the harmonization of biobanking practices, the promotion of ethical standards, and the formulation of best practices for the sharing of biological data.
Biobank-based publications aim to disseminate scientific findings obtained from the processes of collecting, storing, and analyzing biological specimens. These publications present results related to innovative technologies used in biobanking, quality control methods for biological samples, optimization of long-term storage conditions, and data management practices. Accordingly, these publications contribute to advancing knowledge in essential areas such as the harmonization of biobanking practices, the promotion of ethical standards, and the formulation of best practices for the sharing of biological data.
The use of IBG-Biobank materials may require a case-specific agreement in accordance with the relevant protocols, executed agreements, and Intellectual Property Rights provisions. The user is obligated to appropriately acknowledge IBG-Biobank as the supplier of the biological materials in all study outcomes, reports, and publications, and is expected to include a statement of appreciation. The use of IBG-Biobank materials shall be acknowledged as follows, in accordance with the relevant protocols and the Intellectual Property Rights provisions:
“The authors gratefully acknowledge the Izmir Biomedicine and Genome Center Biobank and Biomolecular Resources Platform (IBG-Biobank) for providing access to its facilities, services, and biomolecular resources. The human biospecimens and associated data used in this study were collected, processed, stored, and made available by the IBG-Biobank in accordance with its standard operating procedures and with the approval of the relevant ethics committee (Ethics Committee Approval No: XXX).”
Otherwise, we hereby inform you that the necessary legal and administrative evaluations may be carried out within the framework of the applicable legislation.
For inquiries: biobank@ibg.edu.tr